SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950172-03-002119
Filing Date
2003-06-26
Accepted
2003-06-26 16:36:20
Documents
4

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D pal110315.txt SC 13D 24675
3 EXHIBIT 1 pa111022.txt EX-99 278556
4 EXHIBIT 2 pa111021.txt EX-99 26979
5 EXHIBIT 3 pa110994.txt EX-99 27470
  Complete submission text file 0000950172-03-002119.txt   359508
Mailing Address
Business Address 201 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-48459 | Film No.: 03758920
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
NOVUSPHARMA (Filed by) CIK: 0001246369 (see all company filings)